Description:

The ticker ABOS refers to Axonics Modulation Technologies Inc., a medical device company listed on the New York Stock Exchange (NYSE). Axonics specializes in developing and commercializing novel technologies for the treatment of bladder and bowel dysfunction. The company's flagship product, the Axonics r-SIM™ System, is an implantable sacral neuromodulation (SNM) device designed to provide patients with a long-lasting therapy option for managing symptoms associated with overactive bladder, fecal incontinence, and urinary retention. With its innovative approach to healthcare solutions, Axonics aims to significantly improve the quality of life for individuals suffering from these conditions.

Data:

Yields: